plasma of fatty acid concentration will elicit PDH inactivation in the fed state (Jin et al., 1988) . From the present results it can be concluded that the pressure overload induced by aortic constriction can oppose the effects of an increased In starvation, inhibition of the pyruvate dehydrogenase complex (PDH) is associated with activation of PDH kinase secondary to increased fat oxidation through increased mitochondrial acetyl-CoA/CoA and N A D H / N A D + concentration ratios (for review, see Randle, 1986) . However, acute inhibition of mitochondria1 fat oxidation by 2-tetradecylglycidate ( T D G ) does not lead to reactivation of hepatic PDH in starved rats (Caterson et al., 1982) , implying that the assumed fall in acetyl-CoA/CoA and N A D H / N A D + ratios and resultant inhibition of PDH kinase is not sufficient in itself to permit reactivation. Similarly, hepatic PDH re-activation is not observed in starved rats after the administration of dichloroacetate (DCA), a pyruvate analogue which inhibits PDH kinase directly (Holness & Sugden, 1987) .
Because of the failure to reactivate hepatic PDH by inhibition of PDH kinasc, we speculated that activation of PDH phosphatase might additionally be necessary (Holness & Sugden. 1087) . possibly by insulin which has been demonstrated to increase PDH activity via increased PDH phosphatasc activity in adipose tissue (Marshall et al., 1984; Thomas & Denton, 1986) . In liver, the effects of insulin on PDH have been inconsistent. Increased hepatic PDH activities have been observed after the injection of a supraphysiological dose of insulin Ahhreviations used: PDH, pyruvate dehydrogenase complex; TDG. 2-tetradecylglycidate; DCA, dichloroacetate; MPCA. 5-methylpyrazole 3-carboxylic acid; PDHa, active form of PDH.
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( Wieland et ul., 1972; French et al., 1988) , but PDH activity is not decreased after the injection of anti-insulin serum (Stansbie et al., 1976) . Rapid effects of insulin to increase PDH have been observed in isolated hepatocytes from fed rats (Assimacoupolos-Jeannet et al., 1982) , and more recently, Marchington et al. ( 1987) demonstrated that culture of hepatocytes from starved rats with physiological insulin concentrations leads to a 2-fold increase in PDH VOl. 16 BIOCHEMICAL SOCIETY TRANSACTIONS activity associated with decreased PDH kinase activity, but only after a lag period (2-4 h). In contrast, in starved rats pretreated with DCA, insulin can induce large increases in hepatic PDH activity within 30 min (Holness R: Sugden, 1987) , suggesting a further mechanism of action. T h e present series of experiments was undertaken to examine this in more detail. Female Wistar rats (180-220 g) were fed ud lihitiim or starved for 48 h before sampling. Insulin. D C A and 5-methylpyrazole 3-carboxylic acid (MPCA) were administered at the doses and by the methods given in Holness & Sugden ( 1987) . T D G was administered intragastrically (2.5 mg/100 g body wt.). T h e active form of PDH (PDHa) and citrate synthase were measured in liver extracts (for details see Caterson et ul., 1982) . D C A and insulin were individually without effect on hepatic PDH in 48-h-starved rats, but the administration of insulin to rats pretreated with D C A led to an approx. 10-fold increase in activity within 30 min (Table I ) . Re-activation was also observed after 15 min exposure, but was less substantial than that after 30 min ( Caterson et ul., 1982) . Re-activation was not observed even after 4 h (results not shown). Again. pretreatment of starved rats, this time with TDG, permitted a significant increase in hepatic PDH activity in response t o insulin within 15 min. More marked re-activation was observed if exposure was prolonged ( Table 1 ) .
Because the effects of insulin in DCA-pretreated rats were not mimicked by inhibition of lipolysis by MPCA. it was assumed that insulin achieved re-activation other than via inhibition of fat oxidation, and activation of PDH phosphatase was proposed as a potential mechanism (Holness & Sugden. 1987 . see also Table 1 ). However, despite inhibition o f lipolysis after re-feeding, mitochondrial fat oxidation may continue in the liver (Holness et ul., 1987) . and by analogy, while inhibition of lipolysis was ineffective in achieving hepatic PDH re-activation, the effect of insulin in DCAtreated rats could be mimicked by inhibition of mitochondrial fat oxidation with TDG (Table 1) . Consequently, insulin may exert its effects on DCA-treated rats by suppressing mitochondrial fat oxidation and inactivating PDH kinase. Nonetheless, the effect of insulin in TDG-treated rats indicates that it may have an additional effect. which may involve either further inhibition of PDH kinase o r activation of PDH phosphatase. Cytidine 3', S'-cyclic monophosphate (cyclic C M P ) has now been established as a third naturally occurring cyclic nucleotide in mammalian tissues (Newton er ul., 1983 .
Several cyclic nucleotidc phosphodiesterases have been found to possess activity with cyclic C M P as substrate; the two most active are an enzyme with apparent absolute specificity for cyclic C M P (Newton & Salih, 1983 , 1984 ) and a second phosphodiesterase with similar activities with both the 2', 3'-and 3', 5'-isomers of cyclic AMP, cyclic G M P and cyclic C M P (Helfman et ul., 1978 (Helfman et ul., , 1981 (Helfman et ul., , 1984 Helfman & Kuo, 1982u) , referred to as cyclic-CMP-specific phosphodiesterase and multifunctional phosphodiesterase, respectively. Comparison of these two enzymes revealed some significant differences and leads to interesting hypotheses concerning their role in cyclic C M P metabolism.
Cyclic-CMP-specific phosphodiesterase was extracted from rat liver then purified to homogeneity as previously described (Newton & Salih, 1986) and the multifunctional phosphodiesterase was extracted and partially purified from rat liver by a modification of the procedure described by Helfman er ul. ( 1984) . Cyclic C M P phosphodiestcrasc activity was assayed as previously described (Newton &L Salih, 1986) . T h e cyclic-CMP-specific phosphodiestcrase had a lower M , (2.8 x 10') than that of the multifunctional enzyme (3.3 x 10'). but the amino acid composition, in particular the presence in the former o f significantly morc cysteine, aspartate and argininc residues per mol, indicates that the lower-M, enzyme is not merely a largc fragment of the larger phosphodiesterase. Antisera raised in albino Swiss mice against the cyclic-CMP-specific phosphodiesterase showed little or no binding affinity for calmodulin/Ca' + -activated, cyclic-GMP-stimulated, low-K,,, (cyclic A M P ) and light-activated cyclic G M P phosphodiesterases from :I variety of tissue sources. T h e multifunctional phosphodiesterase possessed binding affinity for the anti-cyclic-CMPspecific phosphodiesterase serum greater than that of the enzymes listed above, but to attain comparablc degrees of inhibition of enzyme activity the requisite concentration of antiserum was two orders of magnitude greater with thc multifunctional phosphodiesterase than with the cyclic-CMP-specific enzyme.
In addition to this immuno-cross-reactivity, the cyclic-CMP-specific and multifunctional phosphodiesterases possess a number of similar properties including pH optima (7.2 and 7.0, respectively), isoelectric points (4.2-4.4 and
